CliffBio
small molecule

ALBUTEROL SULFATE

ALBUTEROL SULFATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameALBUTEROL SULFATE
Active ingredientALBUTEROL SULFATE
StrengthEQ 0.083% BASE
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalFebruary 2007
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.